About
Melanie Matheu is a biotech founder and scientist focused on immunology, tissue engineering, and laser-based bioprinting. She founded Prellis Biologics in 2016 and later became its CTO and board member after a CEO transition in 2022. She is also co-founder and CSO of Lyric Bio, which is developing next-generation biomanufacturing for donor-derived therapeutics.
Areas of interest
biotechimmunologytissue engineeringlaser-based bioprintingantibody therapeuticsdrug discoveryregenerative medicinebiomanufacturing